Johnson & Johnson lifts profit outlook on strong demand for top-seller Stelara
Trend Macro Chief Investment Officer Donald Raskin reacts to rising oil prices as attack on Israel could increase tensions in the Middle East Johnson & Johnson raises its 2023 profit forecast in its first earnings report since spinning off its consumer health business, putting the company’s fate more closely tied to sales of blockbuster products […]
